C27 | Outcomes of participants switching from F/TDF to F/TAF for PrEP: week 48 results from the DISCOVER open label phase | Oral abstract session with live Q&A | PrEP |
C27 | Preferences for implementing long-acting injectable pre-exposure prophylaxis among cisgender men who have sex with men in the US | Oral abstract session with live Q&A | PrEP |
C27 | Understanding participant experiences and preferences in an injectable PrEP trial: a qualitative sub-study of barriers, facilitators, and preferences for PrEP use among MSM and TGW | Oral abstract session with live Q&A | PrEP |
C27 | HIV pre-exposure prophylaxis amongst most-at-risk populations in Cameroon: lessons learnt from the CHAMP project | E-poster | PrEP |
C27 | Substantial increase in HIV risk behaviors and poor PrEP adherence among men who have sex with men during the COVID-19 pandemic: an observational longitudinal study in four cities of China | E-poster | PrEP |
C27 | Acceptability of and preferences for long-acting injectable PrEP (LAI-PrEP) and other PrEP modalities among sexual minority men in Nigeria, Africa | E-poster | PrEP |
C27 | Risk of HIV infection, knowledge and use of pre-exposure prophylaxis (PrEP) among transgender and gender non-binary adults | E-poster | PrEP |
C27 | Pre-exposure prophylaxis (PrEP) use among MSM in Brazil is associated with greater HIV knowledge and lower internalized homonegativity | E-poster | PrEP |
C27 | How MSM PrEP users accommodate PrEP with other effective HIV prevention tools: analysis of prevention effective adherence | E-poster | PrEP |
C27 | High interest in long-acting injectable HIV pre-exposure prophylaxis among nationwide online sample of United States men who have sex with men, 2019 | E-poster | PrEP |